Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 107-116, May 2006

Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphoma

  • Sharon K. Steingass

      Affiliations

    • Corresponding Author InformationAddress correspondence to Sharon K. Steingass, RN, MSN, AOCN®, Clinical Practice and Professional Education, City of Hope National Medical Center, 1500 E. Duarte Rd, Duarte, CA 91010

Department of Clinical Practice and Professional Education, City of Hope National Medical Center, Duarte, CA

Objective

To explore the role and outcomes using hematopoietic cell transplantation (HCT) as a treatment option with aggressive, follicular, mantle, T-cell, and HIV related non-Hodgkin’s lymphoma (NHL).

Data Sources

Research and review articles and textbooks.

Conclusion

High-dose chemotherapy and/or radiation therapy followed by HCT has been used to overcome resistance to standard-dose therapy and has been explored over the past 40 years and has shown long-term survival of approximately 10% to 50% in patients with relapsed or refractory lymphoma.

Implications for Nursing Practice

Nursing plays a significant role in the assessment and management of patients throughout the course of HCT.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(06)00015-5

doi:10.1016/j.soncn.2006.01.006

Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 107-116, May 2006

Article Tools